BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...
The reported cancellation is the second time a federal-level vaccination panel meeting has been affected since Robert F.
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
It's the second such disruption to a federal vaccine advisory panel since Robert F. Kennedy Jr. became the nation’s top ...
A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for ...
The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s efforts to develop a RNA-based vaccine for ...
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss ...
The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.
The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in ...